Delivery Order SPE2DB24D1205-SPE2DB24FCVAC

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COMIRNATY COVID-19 vaccine syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,467.00 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024, with an ultimate completion date of November 21, 2024. The contract is not designated as a set-aside award. As a large Indefinite Delivery Contract (IDC) holder with the DLA valued at $999,999,999...
The federal contract award provides for the delivery of COMIRNATY (COVID-19 vaccine) syringes to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $2,200.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply the syringes for individuals aged 12 and up through September 2024. This contract award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes in 0.3 mL dosages for individuals 12 years and older. The $2,961.16 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 20, 2024. The contract has an ultimate completion date of January 14, 2025 and does not utilize any set-aside designation, indicating open competition. This award is likely part of a...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes, 0.3 mL, for individuals 12 years and older. The Ceiling Value of the award is $2,961.16. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes to the Defense Logistics Agency (DLA). The $3,577.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes with a volume of 0.3 mL, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,441.74 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of December 19, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and up. The contract, valued at $7,155.60, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, and the ultimate completion date is November 26, 2024. The contract was not designated with a set-aside requirement, indicating...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for $2,986.65. It is a firm fixed-price delivery order contract without a set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen...
This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and up, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,293.36 and a completion date of November 27, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $1,800.76 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and above, with a completion date of September 10, 2024. The award is not a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCVAC
    Delivery Order

This federal contract award is for the delivery of COMIRNATY (COVID-19 vaccine) syringes, 0.3 mL, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,310.25 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on September 24, 2024, with a completion date of September 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/24/24, 9:14 AM